Skip to main content
. 2021 Oct 3;37(6):1497–1505. doi: 10.1002/joa3.12642

TABLE 2.

Comparison between the zero‐fluoroscopy group and control group

Zero‐fluoroscopy group Control group Statistical significance
Age (y.o.) 49 ± 16 47 ± 15 P = .79 a
Gender 40% Male 27% Male P = .2 c
60% Female 73% Female
Hypertension 20% 27% P = 1 c
Diabetes mellitus 10% 9% P = 1 c
Hyperlipidemia 10% 27% P = .58 c
Obesity (BMI >30) 30% 36% P = 1 c
Cardiomyopathy 50% 54% P = 1 c
LVEF (%) 52 ± 11% 47 ± 13% P = .3 a
PVC density prior to ablation (% and absolute number) 24.8 ± 7%

25.6 ± 7%

% P = .82 a

Absolute number: 25 300 ± 10 090 Absolute number: 34 813 Absolute number: P = .57 b
Total procedure time (min) 269 ± 56 229 ± 60 P = .127 a
Total ablation time (s) 324 ± 211 292 ± 178 P = .71 a
Number of RF 1 lesions 6 ± 5 8 ± 7 P = .64 b
Fluoroscopy time (min) 0 22 ± 10 P < .01 b
PVC suppression during ablation 80% (8/10) 55% ( 6/11) P = .36 c
Procedure complications 10% (1/10) 0% (0/11) P = .48 c
PVC recurrences follow‐up 30% (3/10) 27.3% (3/11) P = 1 c

Abbreviations: BMI, Body Mass index; LVEF, Left ventricular ejection fraction; PVC, Premature ventricular complex; RF, Radiofrequency.

a

Student's t test.

b

Mann‐Whitney U test.

c

Fisher's exact test.